Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Debt & Borrowing

Supriya Lifescience Debt & Borrowing

Supriya Lifescience Ltd informed exchanges that it does not qualify as a 'Large Corporate' per SEBI criteria for FY 2026-27. The company reported nil outstanding borrowings and an A+ credit rating from India Ratings. This disclosure confirms compliance with debt-market borrowing framework requirements.

Source

BSE filing, NSE: SUPRIYA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Supriya Lifescience Ltd: key numbers

Share price
₹869.30
Market cap
₹6,996 Cr
Revenue (annual)
₹827.9 Cr
Net profit (annual)
₹209.1 Cr
P/E (TTM)
35.3×Sector 48.7×
Promoter holding
68.30%+0.00% QoQ
FII holding
6.45%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Supriya Lifescience Ltd

All →

Other debt & borrowing announcements

All →